Tag: MRGOO3

Age and number of islet autoantibodies associated with diabetes risk

The antibody drug conjugate MRGOO3 is a promising for use in EGFR-expressing cancers

byKassandra McFarlaneand1 others

May 16, 2022

1. The median progression free survival for all cancer-types was 2.8 months. 2. Most of the adverse events (AEs) were ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage

No Result

View All Result